Life Sciences Archives - Page 29 of 32

Perceptive Imaging Names Doug Fulling as CEO to Lead Next Phase of Growth and Innovation

October 9, 2025

Affinia Therapeutics Raises $40 Million Series C to Advance Next-Generation Gene Therapies for Cardiovascular and Neurological Diseases

October 7, 2025

RevBio Awarded $2.2 Million NIH Grant to Advance Minimally Invasive Use of TETRANITE® for Treating Spine Fractures

October 6, 2025

THIS WEEK'S STORIES

Perceptive Imaging Names Doug Fulling as CEO to Lead Next Phase of Growth and Innovation

October 9, 2025

Vensana Capital Launches Vensana Innovation, Appoints Thomas Tu, M.D., as Venture Partner and CEO

October 7, 2025

Los Angeles Jury Awards Nearly $1 Billion Against Johnson & Johnson in Mesothelioma Talc Case

October 8, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Life Sciences

Loomis Sayles Partners with ICE Climate to Enhance Global Climate Risk Analysis

Jefferson River Capital Launches Jefferson Life Sciences, a New Early-Stage Investment Firm Focused on Human Health Innovation

Gradiant Expands ForeverGone PFAS Destruction Platform with Breakthrough Cost and Deployment at Munich Airport

Clean Harbors to Raise Used Oil Collection Prices Through Safety-Kleen Subsidiary

Clean Harbors Study Shows PFAS Incineration Surpasses Latest EPA Standards

Most Read

Bristol Myers Squibb and TV Host Gail Simmons Launch Initiative to Reduce Stigma and Build Support for People Living with Schizophrenia

Urban Green Council Honors Suffolk Chairman and CEO John Fish for Leadership in Sustainable Building

Pulse Biosciences Reports Positive First-in-Human Results for nPulse Cardiac Surgical System at European Cardio-Thoracic Surgery Meeting

Tilak Healthcare Secures Reimbursement for Odysight, the First Remote Ophthalmology Monitoring Solution, Under France’s PECAN Program

EDITOR PICKS

Perceptive Imaging Names Doug Fulling as CEO to Lead Next Phase of Growth and Innovation

Affinia Therapeutics Raises $40 Million Series C to Advance Next-Generation Gene Therapies for Cardiovascular and Neurological Diseases

RevBio Awarded $2.2 Million NIH Grant to Advance Minimally Invasive Use of TETRANITE® for Treating Spine Fractures

THIS WEEK'S STORIES

Perceptive Imaging Names Doug Fulling as CEO to Lead Next Phase of Growth and Innovation

Vensana Capital Launches Vensana Innovation, Appoints Thomas Tu, M.D., as Venture Partner and CEO

Los Angeles Jury Awards Nearly $1 Billion Against Johnson & Johnson in Mesothelioma Talc Case

POPULAR CATEGORY

ABOUT US

FOLLOW US